Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
June Sherie Almenoff currently holds 30,000 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, June Sherie Almenoff has been a net seller of BCLI stock. They have purchased $320.9K and sold $13.3M worth of shares.
June Sherie Almenoff's most recent insider trade was on Jan 9, 2026, when they sold 30,000 shares at $0.00 per share.
June Sherie Almenoff serves as Executive at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have executed 40 insider transactions totaling $13.6M over their tenure at the company.
June Sherie Almenoff holds the position of Executive at BRAINSTORM CELL THERAPEUTICS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
June Sherie Almenoff has shown a selling trading pattern, with $320.9K in total purchases and $13.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by June Sherie Almenoff was on Feb 4, 2014, when they sold $10.7M worth of FURX shares. This transaction involved 93,395 shares at $114.60 per share.
June Sherie Almenoff currently owns 30,000 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of June Sherie Almenoff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. June Sherie Almenoff has 40 Form 4 filings on record as an insider at BRAINSTORM CELL THERAPEUTICS INC..
Set alerts for June Sherie Almenoff and 40,000+ other insiders.